A Harvard University study has found that long-term depression in people over 50 could more than double their risk of having a stroke. The risk remains significantly high even after the depression eases.
Dying Matters: Talk, Plan, Live
During Dying Matters Awareness Week (May 18-24), the Public Health Agency (PHA) is urging everyone to take the opportunity to talk openly with those closest to them about dying, death and bereavement. This year’s theme is ‘Talk, Plan, Live’ (hashtag #YODO, which stands for You Only Die Once).
To the Edge of the Sky: the Fight to Save Children’s Lives and End Duchenne Muscular Dystrophy
New drugs are being developed to treat Duchenne Muscular Dystrophy — and many other rare diseases — but the treatments are stalled at the FDA. A new Kickstarter campaign is raising funds to complete a documentary about parents fighting to stop Duchenne Muscular Dystrophy and gain access to potentially life-saving drugs before the disease kills their children.
23andMe Aims to Use Genetic Data to Develop Drugs
In a big shift of focus, the personal genomics company 23andMe recently announced the creation of a new therapeutics group with the intention of developing new therapies for both common and rare diseases.
kwiKBio Aims to Fast Track Research with Crowdsourcing Campaign
kwiKBio believes it’s taking too long to solve diseases and create cures. The company aims to combine advanced semantic web bioinformatics with contract research organization (CRO) business development in an e-commerce biomedical research portal. Think Wikipedia with an interactive research component coupled with Expedia for purchasing a ticket to a laboratory test.